Rule 10b5-1 plans: how employees and insiders sell company stock on a pre-set schedule
How US employees and insiders use Rule 10b5-1 plans to diversify on autopilot, sell through blackout windows, and earn an affirmative defense against insider-trading claims.
You are a senior engineer at a public company. Your RSUs vest four times a year, the stock is now most of your net worth, and you know you should be selling some of it down. But every time a trading window opens, the price is "obviously" about to recover, so you wait — and then the window closes, the next earnings blackout begins, and you are stuck holding the whole position for another two months. Meanwhile the one quarter you finally decided to sell, you happened to know about an unannounced deal, and your compliance team made you cancel the trade.
This is the exact problem a Rule 10b5-1 plan solves. You decide the rules once, while your hands are clean, and then a broker executes them on schedule no matter what you later know or how you feel about the price. It is the closest thing the securities laws offer to selling concentrated company stock on legal, emotion-proof autopilot.
The 30-second answer: A Rule 10b5-1 plan is a written schedule, adopted in good faith while you hold no material non-public information, that tells your broker exactly how to sell (or buy) company stock — by date and quantity, by price trigger, or by formula. Its core benefit is an affirmative defense against insider-trading liability, and the practical benefit is that selling continues through blackout windows and earnings cycles. After the SEC's 2023 amendments, directors and officers face a cooling-off period of 90 days (or two business days after the next 10-Q/10-K, capped at 120 days) before trading begins; other employees wait 30 days. The plan controls timing, not tax rates — each sale is taxed normally.
This guide is the insider-trading-aware companion to the diversification playbook. The playbook explains why you should trim a concentrated employer position and where the proceeds should go. This one explains the legal machinery that lets directors, officers, and senior employees actually sell that stock without tripping over insider-trading rules — and why even ordinary employees often adopt one for the discipline. It is written for US residents trading US-listed company stock.
What a Rule 10b5-1 plan actually is
A Rule 10b5-1 plan is a written, pre-set instruction — a contract with your broker — that commits you in advance to buy or sell a set amount of company stock on specified terms. Those terms can be a calendar schedule (sell 500 shares on the tenth business day of each quarter), a price condition (sell 1,000 shares whenever the price is at or above $X), or a written formula that determines amount, price, and date. The defining feature is timing: you put the instructions in place while you are not in possession of material non-public information (MNPI), and you do it in good faith, not as a scheme to evade the rules.
MNPI is the heart of insider-trading law. It is information that a reasonable investor would consider important in deciding whether to trade and that has not been released to the public — an unannounced acquisition, a quarter that is about to badly miss, a major contract win or loss, a drug-trial result. If you trade while holding MNPI, you risk civil and criminal liability under Rule 10b-5. The genius of a 10b5-1 plan is that it separates the decision to trade from the execution. You decide when your hands are clean. The broker executes later, and the fact that you happen to learn confidential news in the meantime does not taint trades you no longer control.
Crucially, the plan must take discretion out of your hands. Once it is running, you cannot tell the broker to skip a trade because the price looks bad, or to sell extra because you have a hunch. If you retain that kind of influence, you no longer have a valid plan and you lose the defense. Some plans appoint the broker as the agent who decides execution mechanics within the formula; what you cannot do is keep second-guessing the substance.
Bottom line: A Rule 10b5-1 plan is a written, good-faith instruction to your broker — by date, by price, or by formula — adopted while you hold no material non-public information, which then executes on its own and removes your discretion to trade on what you later learn.
The affirmative defense, and selling through blackouts
There are two reasons to use a plan, and they serve two different audiences.
The first is the affirmative defense. Rule 10b5-1 was created precisely because corporate insiders are almost always in possession of some confidential information — that is their job. Without a safe harbor, a director could never sell a share without risking a regulator second-guessing what she knew that day. The rule says: if you can show the trade was executed under a plan you adopted in good faith, at a time when you held no MNPI, then the trade is presumed not to be "on the basis of" inside information. The burden flips. Instead of you having to prove a negative after the fact, you point to the dated, written plan that predates the news. This is what makes the tool indispensable for directors, officers, and anyone who routinely holds MNPI.
The second is continuity through blackout windows. Most public companies impose blackout periods — typically the weeks around quarter-end and earnings — when insiders and often all employees are barred from trading. They also impose ad hoc blackouts around deals. If you sell only by hand, you can transact for maybe a few weeks each quarter, and every blackout freezes your diversification plan. A 10b5-1 plan keeps executing straight through blackouts, because the trades were pre-authorized when you were clear. For a senior employee trying to reduce a position steadily, this turns a stop-start dribble into a smooth, year-round sell-down.
Note what the defense does not do. It does not protect a plan adopted while you held MNPI. It does not protect a plan you manipulated by canceling trades based on news. And after the 2023 amendments, directors and officers must also certify, at adoption, that they are not aware of MNPI and are acting in good faith. The defense is strong, but it is conditional on doing it right.
Bottom line: A plan buys you two things — a legal affirmative defense that the SEC presumes your trades were not based on inside information, and the practical ability to keep selling through blackout windows and earnings cycles instead of waiting all year for an open trading window.
The disciplined sell-down: diversify on autopilot
Set the law aside for a moment, because the behavioral benefit is what makes ordinary employees adopt plans even when they do not strictly need the defense. Concentrated employer stock does not get diversified because people wait for the "right" price. A 10b5-1 plan makes the decision for you on a schedule, removing the temptation to time it.
Worked example. A quarterly sell-down versus trying to time it
You hold company stock and adopt a plan to sell 500 shares on a fixed date each quarter for one year, regardless of price. The stock is volatile that year. Here is what the plan does, mechanically, with illustrative prices:
| Quarter | Shares sold | Price | Proceeds |
|---|---|---|---|
| Q1 | 500 | $80 | $40,000 |
| Q2 | 500 | $62 | $31,000 |
| Q3 | 500 | $95 | $47,500 |
| Q4 | 500 | $73 | $36,500 |
| Total | 2,000 | avg $77.50 | $155,000 |
You sold 2,000 shares for $155,000, an average realized price of $77.50. The point is not that $77.50 is the best price — it is that you actually diversified $155,000 out of a single stock without ever making a stomach-churning "should I sell today?" decision. Compare the employee who decided to wait for the stock to "get back to $95": they sold nothing in Q1, Q2, and Q4, and in Q3, when the price finally hit $95, the open window happened to fall inside an earnings blackout, so they could not trade at all. They end the year still fully concentrated. The plan's worst feature — that it ignores your opinion about the price — is exactly why it works.
A scheduled sell-down also dollar-cost-averages your exits. By selling the same share count every quarter, you sell more dollars when the price is high and fewer when it is low only if you fix the dollar amount; with a fixed share count you sell a steady quantity and let the average fall out naturally. Either design beats the all-or-nothing instinct that keeps concentrated positions concentrated.
Bottom line: Even without needing the legal defense, a 10b5-1 plan is a commitment device that diversifies a concentrated position on a calendar — selling a fixed quantity every quarter beats waiting for a price you will never feel good enough about, especially when blackouts block the windows you were waiting for.
Price-trigger and formula plans
Not every plan is a flat calendar schedule. You can also build a plan around price conditions, which lets you express a view about value without retaining any discretion at the moment of the trade.
Worked example. A price-trigger plan
You adopt a plan instructing the broker: sell 1,000 shares whenever the stock trades at or above $120, up to a maximum of 4,000 shares over the plan's term. You believe the stock is fairly valued around $120 and want to lighten up only into strength, but you do not want to be on the desk watching the tape and deciding in the moment — that is exactly the discretion the rule forbids.
Suppose over the next year the stock crosses $120 on three separate occasions. The broker sells 1,000 shares each time, at the first qualifying execution price each day the condition is met under the plan's terms:
| Trigger event | Condition met at | Shares sold | Proceeds |
|---|---|---|---|
| First cross above $120 | $121 | 1,000 | $121,000 |
| Second cross above $120 | $124 | 1,000 | $124,000 |
| Third cross above $120 | $120 | 1,000 | $120,000 |
| Total | 3,000 | $365,000 |
You sold 3,000 shares for $365,000, all at or above your target, and you never made a single discretionary call once the plan was running. The remaining 1,000-share allotment simply never triggered because the price did not cross again. A formula plan can combine conditions — for example, "sell on a date and only if above a floor price" — but every input must be fixed in writing at adoption, with no later judgment from you.
Price triggers carry a real risk worth naming: the stock may never reach your trigger, in which case the plan does nothing and you stay concentrated. A pure price-trigger plan is therefore a weaker diversification tool than a flat calendar schedule, because it makes selling contingent on a price the market may not deliver. Many people blend the two — a baseline quarterly sale that always happens, plus extra tranches that trigger only into strength.
Bottom line: Price-trigger and formula plans let you sell only into strength without retaining illegal discretion, but a pure price trigger may never fire — so if diversification is the goal, anchor the plan with an unconditional calendar component and treat triggers as the bonus.
The 2023 amendments and the cooling-off period
The SEC tightened Rule 10b5-1 substantially in amendments effective in 2023, after years of evidence that some insiders were gaming the safe harbor. If you are adopting a plan now, these are the rules that govern it.
The headline change is the cooling-off period — a mandatory wait between adopting a plan and the first permitted trade.
| Plan participant | Cooling-off period before first trade |
|---|---|
| Director or officer | The later of 90 days after adoption, or 2 business days after filing the 10-Q/10-K for the quarter of adoption — capped at 120 days |
| Any other employee | 30 days after adoption |
Worked example. A director's cooling-off timeline
A director adopts a plan on March 1, 2026. Ninety days later is May 30, 2026. The company's fiscal quarter ends March 31 and it files its Form 10-Q on May 5, 2026; two business days after that is roughly May 7, 2026. The director must wait for the later of those two dates — and 90 days (May 30) is later than May 7 — so the first trade cannot occur until May 30, 2026. The 120-day cap is not binding here because 90 days has not exceeded it. If, instead, the 10-Q had been delayed and filed on July 1, two business days after would be later than 90 days, and the director would wait until that date — but never beyond 120 days from adoption (roughly June 29, 2026), at which point the cap takes over. The practical lesson: adopt early, because nothing sells for at least three months.
Beyond the cooling-off period, the 2023 amendments added several constraints. They limit overlapping plans — you generally cannot run two open-market plans in the same securities at once, with narrow exceptions. They generally restrict you to one single-trade plan per 12-month period. They codified the good-faith requirement, meaning you must not only adopt in good faith but operate the plan in good faith throughout. They require directors and officers to certify at adoption that they hold no MNPI and are acting in good faith. And they expanded public disclosure: companies must disclose adoption, modification, and termination of insiders' plans, and insiders' Forms 4 and 5 must flag trades made under a plan.
Bottom line: Under the 2023 amendments, directors and officers wait the later of 90 days or two business days after the next 10-Q/10-K (capped at 120 days), other employees wait 30 days, overlapping and single-trade plans are restricted, and directors and officers must certify good faith and no MNPI at adoption.
Tax: the plan controls timing, not rates
A persistent misconception is that putting sales inside a 10b5-1 plan changes how they are taxed. It does not. The plan is a trading mechanism; the tax follows the ordinary rules for selling stock, determined entirely by your cost basis and holding period.
For RSU shares, the vest value was already taxed as ordinary income when the shares vested — that is your cost basis. What happens at sale depends on what the stock did since vest:
| Lot sold | Holding period at sale | Tax treatment |
|---|---|---|
| Sold at or near vest | Days | Roughly tax-neutral — little gain or loss above the basis already taxed |
| Held more than one year, appreciated | More than 12 months | Long-term capital gain: 0% / 15% / 20% federal, plus 3.8% NIIT at higher incomes |
| Held one year or less, appreciated | 12 months or less | Short-term capital gain: ordinary rates up to 37% |
So a plan that sells freshly vested shares each quarter is largely tax-neutral on the sale itself — you are converting already-taxed vest value into cash and diversification. A plan that sells older, appreciated lots realizes capital gain, and whether that gain is long-term or short-term turns on the holding period, not on the existence of the plan. If you have specific lots you would prefer to sell first — say, the highest-basis lots to minimize gain, or the long-term lots to get the preferential rate — that lot selection should be built into the plan's design and coordinated with your broker at adoption, because once the plan runs you cannot reach in and pick lots based on this year's tax bill.
The takeaway is to keep two decisions separate. The 10b5-1 plan answers when and how much to sell, driven by diversification and insider-trading law. Your CPA answers which lots and what it costs in tax, and feeds that back into how the plan is structured before it goes live.
Bottom line: A 10b5-1 plan changes the timing and legality of your sales, never the tax rate — sell-at-vest is roughly neutral, long-term lots get 0/15/20% plus NIIT, short-term lots are taxed as ordinary income, and any lot-selection preference must be designed into the plan up front.
Common mistakes
The errors that void plans or waste their benefit are predictable.
- Adopting while holding MNPI. This is the cardinal sin. If you set up the plan the week before an unannounced deal you already know about, the entire affirmative defense evaporates, and the plan can look like evidence against you rather than protection. Adopt only when your hands are genuinely clean, ideally well before any known catalyst.
- Treating cancellation as a free option. You can cancel a plan, and past trades keep their defense, but canceling repeatedly — especially right before a scheduled trade you suspect will be unfavorable — undermines the good-faith requirement and can taint the whole arrangement. The SEC watches cancel-and-re-adopt patterns closely.
- Modifying and forgetting the cooling-off restart. Any change to the amount, price, or timing of trades is treated as a new plan, which restarts the full cooling-off period. People modify a plan expecting trading to continue and are surprised when nothing executes for another 90 days.
- Retaining discretion. If you keep the ability to tell the broker to skip or resize trades, you do not have a valid plan. The discretion must be gone once it is running.
- Stacking overlapping plans. Running multiple plans in the same stock to cherry-pick which to cancel is exactly what the 2023 amendments restrict. Use one clean plan.
- Assuming a plan replaces your other obligations. A 10b5-1 plan does not exempt you from Section 16 reporting, short-swing profit rules, company blackout policy approvals, or Rule 144 volume limits for affiliates. Those still apply on top of the plan.
Bottom line: Plans fail when you adopt with inside information, cancel or modify them opportunistically, keep discretion over the trades, or assume the plan overrides your other securities-law duties — design it carefully and then leave it alone.
Edge cases
A few situations need specific handling.
Sell-to-cover for tax withholding. Automatic sales to cover RSU vesting taxes are common, and the amendments include accommodations so that genuine sell-to-cover arrangements are not treated as overlapping with your discretionary diversification plan. Confirm with your broker how your equity plan's mandatory withholding sales interact with your 10b5-1 plan.
Affiliates and Rule 144. If you are an affiliate of the issuer (typically directors, officers, and large holders), your sales are also subject to Rule 144 — volume limits, manner-of-sale requirements, and Form 144 filings. A 10b5-1 plan does not lift those; it sits alongside them, and a good plan is sized to stay within 144 limits automatically.
Leaving the company. What happens to a running plan when you resign or are laid off depends on the plan document and company policy — some terminate on separation, some continue. If you are changing jobs, this interacts with the rest of your equity decisions; see the guide on RSUs when changing jobs or being laid off.
Single-trade plans. A plan designed to execute as one transaction is limited to roughly one per 12-month period and gets less protection than an ongoing plan. If your goal is steady diversification, a multi-trade plan is almost always the right structure.
Private-company stock. Rule 10b5-1 is built around open-market trades in public securities. If your shares are in a private company, the plan concept does not map cleanly — your liquidity comes from tender offers and secondaries with their own rules.
Bottom line: Sell-to-cover, Rule 144 limits for affiliates, separation from the company, single-trade restrictions, and private stock all sit outside the simple plan — handle each explicitly rather than assuming the 10b5-1 plan covers them.
The closing read
A Rule 10b5-1 plan is not exotic. It is the boring, standard infrastructure that lets people who are constantly near confidential information sell their company stock without breaking the law — and, just as usefully, it is a commitment device that drags concentrated positions toward diversification on a schedule instead of on a feeling. The legal benefit is the affirmative defense. The human benefit is that the plan does not care whether you think the price is about to recover.
If you are a director, officer, or anyone who routinely holds MNPI, you almost certainly need one to sell at all without risk. If you are an ordinary employee, you may not strictly need the defense, but the autopilot is worth having anyway — it solves the exact problem of windows that close before you act and prices that never feel right. Either way, the design work happens up front, while your hands are clean: set the schedule or the formula, build in your lot preferences with your CPA, respect the cooling-off period, and then resist the urge to touch it. The plan's stubbornness is the whole point.
What it does not do is change your tax bill or replace your other obligations. Pair it with deliberate lot selection, keep it within Rule 144 if you are an affiliate, and slot the proceeds into the broader plan for what diversified money should become.
Cross-references
- The RSU diversification playbook
- Turning RSUs into a retirement corpus: 401(k) and Roth
- The RSU tax-saving playbook: harvesting, NUA, and DAFs
- Funding life goals with RSUs: house, 529, goal-based selling
- How much employer stock is too much
- Completion portfolios around employer stock
- Exchange funds for concentrated stock
- Direct indexing around concentrated employer stock
- Should you sell RSUs at vest or hold
- Sell-to-cover, sell-all, or hold: RSU decisions
- RSUs when changing jobs or being laid off
- The complete US residents RSU guide for 2026
Critical disclaimer: This article describes US securities and tax law as understood as of June 2026 and is general information, not legal, tax, or investment advice. Rule 10b5-1, the SEC's 2023 amendments, Rule 144, Section 16, and the tax treatment of stock sales are complex and fact-specific, and the rules can change. Whether and how to adopt a trading plan depends on your role, your company's policies, and your personal circumstances. Before adopting, modifying, or canceling a Rule 10b5-1 plan, consult qualified securities counsel and a CPA, and follow your company's insider-trading policy and pre-clearance process.
Found this useful? Share it.
Help another Indian working with US RSUs or LRS not get blindsided by this stuff.
About the author

Co-Founder & Chief Executive Officer, Rovia
CFA charterholder with 10+ years across hedge funds and NRI fintech. Covers RSU taxation, equity comp, and cross-border investing for Indian residents. Ex-JP Morgan, Makrana Capital, Zolve.
More about Shivang →Get more like this in your inbox
One practical post a week on US investing & RSU strategy.
Keep reading
What to do with vested RSUs: the diversification playbook for US employees
Vested RSUs leave you over-concentrated in one stock that also signs your paycheck. The diversification playbook: sell-at-vest math, completion portfolios, direct indexing, exchange funds, and 10b5-1 plans.
Exchange funds (swap funds) for a concentrated employer-stock position
How US employees use exchange funds (swap funds) to diversify a large, low-basis employer-stock position tax-deferred — the 7-year lock-up, fees, eligibility, and when an outright sale beats it.
How much employer stock is too much? A concentration-risk deep dive
How US employees size a company-stock position, why employer stock is uniquely risky, and a framework to set a concentration target you can defend.